| Literature DB >> 28382954 |
Yifei Wang1, Yunhua Zhang1, Ronglin Jiang2.
Abstract
This study aimed to study the effect of early traditional Chinese medicine bundle therapy on the prevention of sepsis-associated acute gastrointestinal injury (AGI). This was a multicenter, prospective, observational, non-randomized cohort study of 296 consecutive patients with severe sepsis during 2013/3 and 2014/11; 150 patients received standard treatments (controls) and 146 received traditional Chinese medicine bundle therapy (intervention group) (herbal decoction gavage based on syndrome differentiation, Chinese acupuncture, application of mirabilite, and defecation mixture). D-lactic acid, diamine oxidase, endotoxin, gastrin, motilin, and intra-abdominal pressure were measured. AGI was categorized into four levels. Compared with controls, D-lactic acid, diamine oxidase, endotoxin, gastrin, and intra-abdominal pressure in the intervention group were decreased, and motilin was increased on day 7. AGI incidence in the intervention group was lower than in controls. GIF scores of the intervention AGI II and III groups were lower than in controls. The APACHE II scores of the intervention AGI II, III, and IV groups were lower than in controls. Compared with controls, mechanical ventilation time and ICU stay in the intervention group were shorter, and 28-day overall and AGI-attributed mortality were lower. For elderly patients with severe sepsis, early traditional Chinese medicine bundle therapy could decrease AGI incidence and improve prognosis.Entities:
Mesh:
Year: 2017 PMID: 28382954 PMCID: PMC5382529 DOI: 10.1038/srep46015
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Patient flowchart.
Characteristics of the 296 patients with sepsis.
| Control group (n = 150) | Intervention group (n = 146) | P | |
|---|---|---|---|
| Age (years) | 76.4 ± 13.9 | 76.5 ± 14.0 | 0.927 |
| Male, n (%) | 109 (72.7%) | 109 (74.7%) | 0.792 |
| SOFA score | 8.72 ± 1.51 | 9.02 ± 1.40 | 0.081 |
| APACHE II score | 15.5 ± 2.0 | 15.9 ± 2.0 | 0.085 |
| Original infection sites, n (%) | |||
| Respiratory system | 80 (53.3%) | 76 (52.1%) | 0.787 |
| Digestive System | 37 (24.7%) | 29 (19.9%) | |
| Urinary system | 7 (4.7%) | 10 (6.9%) | |
| Hematogenous infection | 9 (6.0%) | 12 (8.2%) | |
| Intracranial infection | 5 (3.3%) | 4 (2.7%) | |
| Other sites | 12 (8.0%) | 15 (10.3%) | |
| Reason of ICU admission, n (%) | |||
| Respiratory failure | 69 (46.0%) | 75 (51.4%) | 0.918 |
| Circulatory failure | 20 (13.3%) | 18 (12.3%) | |
| Nervous system (epilepsy, apoplexy) | 21 (14.0%) | 16 (11.0%) | |
| Trauma | 17 (11.3%) | 18 (12.3%) | |
| Others | 3 (2.0%) | 2 (1.4%) | |
| Postoperative patient | 20 (13.3%) | 17 (11.6%) | |
| Traditional Chinese medicine syndrome | |||
| Qi activity stagnation | 52 (34.7%) | 45 (30.8%) | 0.773 |
| Qi stagnation and blood stasis | 40 (26.7%) | 36 (24.7%) | |
| Spleen-stomach weakness | 30 (20.0%) | 35 (24.0%) | |
| Internal accumulation of damp-heat | 28 (18.7%) | 30 (20.6%) | |
Laboratory indexes of gastrointestinal function.
| Indexes | Time point | Control group (n1 = 150) (n3 = 150) (n7 = 136) | Intervention group (n1 = 146) (n3 = 146) (n7 = 138) | P |
|---|---|---|---|---|
| D lactic acid (mg/L) | Day 1 | 508.25 ± 285.03 | 506.54 ± 279.74 | 0.960 |
| Day 3 | 392.21 ± 186.26 | 373.01 ± 163.78 | 0.406 | |
| Day 7 | 377.79 ± 204.93 | 321.65 ± 138.78 | 0.044 | |
| Diamine oxidase (U/mL) | Day 1 | 12.98 ± 7.31 | 12.97 ± 7.31 | 0.992 |
| Day 3 | 10.65 ± 5.32 | 11.11 ± 5.84 | 0.530 | |
| Day 7 | 12.36 ± 6.43 | 10.09 ± 4.55 | 0.010 | |
| Endotoxin (eU/ml) | Day 1 | 0.77 ± 0.23 | 0.78 ± 0.21 | 0.630 |
| Day 3 | 0.68 ± 0.18 | 0.63 ± 0.19 | 0.097 | |
| Day 7 | 0.64 ± 0.17 | 0.59 ± 0.17 | 0.035 | |
| Motilin (ng/L) | Day 1 | 273.05 ± 198.18 | 268.55 ± 198.18 | 0.844 |
| Day 3 | 274.08 ± 165.02 | 324.12 ± 201.30 | 0.041 | |
| Day 7 | 320.54 ± 230.24 | 423.02 ± 318.69 | 0.021 | |
| Gastrin (ng/L) | Day 1 | 221.82 ± 177.96 | 216.42 ± 177.63 | 0.794 |
| Day 3 | 216.24 ± 120.75 | 183.79 ± 113.08 | 0.041 | |
| Day 7 | 214.32 ± 121.37 | 176.54 ± 99.14 | 0.037 | |
| Intra-abdominal pressure (mmHg) | Day 1 | 9.77 ± 4.02 | 10.30 ± 2.86 | 0.193 |
| Day 3 | 11.23 ± 4.11 | 9.16 ± 4.12 | < 0.001 | |
| Day 7 | 11.59 ± 3.80 | 10.28 ± 2.61 | 0.012 |
Note: n1, n3, and n7 represent the number of surviving patients on the 1st, 3rd, and 7th days.
Comparison of AGI incidence.
| Groups | Control group (n = 150) | Intervention group (n = 146) | P |
|---|---|---|---|
| AGI (%) | 88 (58.67%) | 69 (47.26%) | 0.041 |
| No AGI (%) | 62 (41.33%) | 77 (52.74%) |
General condition of the patients.
| Control group (n7 = 88) | Intervention group (n7 = 69) | P | |
|---|---|---|---|
| AGI II | |||
| n | 13 (14.8%) | 18 (26.1%) | 0.077 |
| GIF score | 2.7 ± 1.0 | 2.2 ± 0.9 | 0.006 |
| APACHE II score | 12.2 ± 2.5 | 11.3 ± 2.0 | 0.011 |
| AGI III | |||
| n | 68 (77.3%) | 48 (69.6%) | 0.275 |
| GIF score | 2.9 ± 1.0 | 2.4 ± 1.0 | 0.007 |
| APACHE II score | 11.1 ± 2.0 | 10.2 ± 1.9 | 0.013 |
| AGI IV | |||
| n | 7 (8.0%) | 3 (4.4%) | 0.358 |
| GIF score | 4.7 ± 0.7 | 4.6 ± 0.8 | 0.552 |
| APACHE II score | 13.7 ± 1.9 | 13.2 ± 1.6 | 0.023 |
Comparison of the AGI incidence according to APACHE II scores.
| APACHE II < 10, n (AGI incidence) | APACHE II 10–20, n (AGI incidence) | APACHE II > 20, n (AGI incidence) | |
|---|---|---|---|
| Control group (n = 150) | 24 (25.0%) | 70 (51.4%) | 56 (82.1%) |
| Intervention group (n = 146) | 21 (0%) | 67 (31.3%) | 58 (82.8%) |
| P | 0.023 | 0.024 | 1.000 |
Comparison of prognosis between the two groups.
| Parameters | Control group | Intervention group | P |
|---|---|---|---|
| (n = 150) | (n = 146) | ||
| Mechanical ventilation time (days) | 10.4 ± 3.7 | 9.3 ± 3.8 | 0.011 |
| ICU stay (days) | 18.5 ± 10.6 | 14.2 ± 7.9 | 0.035 |
| 28-day mortality | 43.3% | 31.5% | 0.048 |
| AGI-attributable mortality | 8.7% | 2.7% | 0.043 |
Figure 228-day survival curve between the control and intervention groups.